Vorinostat Terminated Phase 2 Trials for Blood Diseases / Bone Marrow Diseases / Myelodysplastic Syndromes Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00486720Phase IIa Vorinostat (MK0683, Suberoylanilide Hydroxamic Acid (SAHA)) Study in Lower Risk Myelodysplastic Syndromes (0683-064)